These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35752817)

  • 21.
    Mäkitie RE; Niinimäki T; Suo-Palosaari M; Kämpe A; Costantini A; Toiviainen-Salo S; Niinimäki J; Mäkitie O
    Front Endocrinol (Lausanne); 2020; 11():393. PubMed ID: 32655496
    [No Abstract]   [Full Text] [Related]  

  • 22. A novel nonsense variant in PLS3 causes X-linked osteoporosis in a Chinese family.
    Wang L; Bian X; Cheng G; Zhao P; Xiang X; Tian W; Li T; Zhai Q
    Ann Hum Genet; 2020 Jan; 84(1):92-96. PubMed ID: 31347706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.
    Wesseling-Perry K; Mäkitie RE; Välimäki VV; Laine T; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2340-2348. PubMed ID: 28379384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Genetic Forms of Childhood-Onset Primary Osteoporosis.
    Kämpe AJ; Mäkitie RE; Mäkitie O
    Horm Res Paediatr; 2015; 84(6):361-9. PubMed ID: 26517534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers in WNT1 and PLS3 Osteoporosis: Altered Concentrations of DKK1 and FGF23.
    Mäkitie RE; Kämpe A; Costantini A; Alm JJ; Magnusson P; Mäkitie O
    J Bone Miner Res; 2020 May; 35(5):901-912. PubMed ID: 31968132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mice lacking plastin-3 display a specific defect of cortical bone acquisition.
    Yorgan TA; Sari H; Rolvien T; Windhorst S; Failla AV; Kornak U; Oheim R; Amling M; Schinke T
    Bone; 2020 Jan; 130():115062. PubMed ID: 31678489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone material properties and response to teriparatide in osteoporosis due to WNT1 and PLS3 mutations.
    Fratzl-Zelman N; Wesseling-Perry K; Mäkitie RE; Blouin S; Hartmann MA; Zwerina J; Välimäki VV; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O
    Bone; 2021 May; 146():115900. PubMed ID: 33618074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcript levels of plastin 3 and neuritin 1 modifier genes in spinal muscular atrophy siblings.
    Yener İH; Topaloglu H; Erdem-Özdamar S; Dayangac-Erden D
    Pediatr Int; 2017 Jan; 59(1):53-56. PubMed ID: 27279027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical Care Use Among Patients with Monogenic Osteoporosis Due to Rare Variants in LRP5, PLS3, or WNT1.
    Verdonk SJE; Storoni S; Zhytnik L; Zhong W; Pals G; van Royen BJ; Elting MW; Maugeri A; Eekhoff EMW; Micha D
    Calcif Tissue Int; 2023 Aug; 113(2):186-194. PubMed ID: 37277619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in Rett syndrome.
    Caffarelli C; Gonnelli S; Pitinca MDT; Camarri S; Al Refaie A; Hayek J; Nuti R
    BMC Med Genet; 2020 Jan; 21(1):21. PubMed ID: 32005172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole exome sequencing reveals potentially pathogenic variants in a small subset of premenopausal women with idiopathic osteoporosis.
    Cohen A; Hostyk J; Baugh EH; Buchovecky CM; Aggarwal VS; Recker RR; Lappe JM; Dempster DW; Zhou H; Kamanda-Kosseh M; Bucovsky M; Stubby J; Goldstein DB; Shane E
    Bone; 2022 Jan; 154():116253. PubMed ID: 34743040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Diagnostics in Routine Osteological Assessment of Adult Low Bone Mass Disorders.
    Oheim R; Tsourdi E; Seefried L; Beller G; Schubach M; Vettorazzi E; Stürznickel J; Rolvien T; Ehmke N; Delsmann A; Genest F; Krüger U; Zemojtel T; Barvencik F; Schinke T; Jakob F; Hofbauer LC; Mundlos S; Kornak U
    J Clin Endocrinol Metab; 2022 Jun; 107(7):e3048-e3057. PubMed ID: 35276006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipocalin-2 is associated with FGF23 in WNT1 and PLS3 osteoporosis.
    Loid P; Hauta-Alus H; Mäkitie O; Magnusson P; Mäkitie RE
    Front Endocrinol (Lausanne); 2022; 13():954730. PubMed ID: 36157448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Mutations in PLOD2 Cause Rare Bruck Syndrome.
    Lv F; Xu X; Song Y; Li L; Asan ; Wang J; Yang H; Wang O; Jiang Y; Xia W; Xing X; Li M
    Calcif Tissue Int; 2018 Mar; 102(3):296-309. PubMed ID: 29177700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel compound heterozygous mutations in SERPINH1 cause rare autosomal recessive osteogenesis imperfecta type X.
    Song Y; Zhao D; Xu X; Lv F; Li L; Jiang Y; Wang O; Xia W; Xing X; Li M
    Osteoporos Int; 2018 Jun; 29(6):1389-1396. PubMed ID: 29520608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plastin 3 in health and disease: a matter of balance.
    Wolff L; Strathmann EA; Müller I; Mählich D; Veltman C; Niehoff A; Wirth B
    Cell Mol Life Sci; 2021 Jul; 78(13):5275-5301. PubMed ID: 34023917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional Insights in PLS3-Mediated Osteogenic Regulation.
    Zhong W; Neugebauer J; Pathak JL; Li X; Pals G; Zillikens MC; Eekhoff EMW; Bravenboer N; Zhang Q; Hammerschmidt M; Wirth B; Micha D
    Cells; 2024 Sep; 13(17):. PubMed ID: 39273077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early-Onset Osteoporosis: Molecular Analysis in Large Cohort and Focus on the PLS3 Gene.
    Mancini M; Chapurlat R; Isidor B; Desjonqueres M; Couture G; Guggenbuhl P; Coutant R; El Chehadeh S; Fradin M; Frazier A; Goldenberg A; Guillot P; Koumakis E; Mehsen-Cêtre N; Rossi M; Schaefer É; Sigaudy S; Porquet-Bordes V; Fontanges É; Letard P; Edouard T; Javier RM; Cohen-Solal M; Funck-Brentano T; Collet C
    Calcif Tissue Int; 2024 Nov; 115(5):591-598. PubMed ID: 39316135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoporosis-pseudoglioma syndrome: description of 9 new cases and beneficial response to bisphosphonates.
    Streeten EA; McBride D; Puffenberger E; Hoffman ME; Pollin TI; Donnelly P; Sack P; Morton H
    Bone; 2008 Sep; 43(3):584-90. PubMed ID: 18602879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype.
    Hosseinibarkooie S; Peters M; Torres-Benito L; Rastetter RH; Hupperich K; Hoffmann A; Mendoza-Ferreira N; Kaczmarek A; Janzen E; Milbradt J; Lamkemeyer T; Rigo F; Bennett CF; Guschlbauer C; Büschges A; Hammerschmidt M; Riessland M; Kye MJ; Clemen CS; Wirth B
    Am J Hum Genet; 2016 Sep; 99(3):647-665. PubMed ID: 27499521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.